- Home
- TXN vs PFE Comparison
TXN vs PFE Comparison
Compare TXN & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXN
- PFE
- Stock Information
- Founded
- TXN 1930
- PFE 1849
- Country
- TXN United States
- PFE United States
- Employees
- TXN N/A
- PFE N/A
- Industry
- TXN Semiconductors
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- TXN Technology
- PFE Health Care
- Exchange
- TXN Nasdaq
- PFE Nasdaq
- Market Cap
- TXN 183.8B
- PFE 166.8B
- IPO Year
- TXN N/A
- PFE N/A
- Fundamental
- Price
- TXN $198.30
- PFE $29.28
- Analyst Decision
- TXN Hold
- PFE Buy
- Analyst Count
- TXN 23
- PFE 12
- Target Price
- TXN $201.50
- PFE $33.91
- AVG Volume (30 Days)
- TXN 4.8M
- PFE 30.6M
- Earning Date
- TXN 10-22-2024
- PFE 10-29-2024
- Dividend Yield
- TXN 2.73%
- PFE 5.74%
- EPS Growth
- TXN N/A
- PFE N/A
- EPS
- TXN 5.77
- PFE N/A
- Revenue
- TXN $16,092,000,000.00
- PFE $55,166,000,000.00
- Revenue This Year
- TXN N/A
- PFE $5.66
- Revenue Next Year
- TXN $13.68
- PFE $3.34
- P/E Ratio
- TXN $34.37
- PFE N/A
- Revenue Growth
- TXN N/A
- PFE N/A
- 52 Week Low
- TXN $139.48
- PFE $25.20
- 52 Week High
- TXN $214.66
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- TXN 43.92
- PFE 50.84
- Support Level
- TXN $198.90
- PFE $28.85
- Resistance Level
- TXN $208.96
- PFE $29.82
- Average True Range (ATR)
- TXN 4.64
- PFE 0.53
- MACD
- TXN -0.60
- PFE 0.04
- Stochastic Oscillator
- TXN 1.66
- PFE 47.26
About TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.